In recent studies within the Non-alcoholic Steatohepatitis Clinical Research Network (NASH CRN), soluble interleukin-2 receptor alpha (IL2RA) levels were observed to increase with fibrosis severity in both adult and pediatric cohorts. Here, IL2RA is linked to metabolic dysfunction-associated steatohepatitis.